Skip to main content
Caplight Logo









Prudentia Sciences

Prudentia Sciences

Private
Cambridge, MassachusettsHealthcare & Life Scienceshttps://www.prudentiasciences.com/

Last Round

Series A

Jan 7, 2026

Total Funding Raised

$34M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Prudentia Sciences is a business/productivity software company that provides an AI-native platform for due diligence, valuation, and dealmaking for the life sciences industry.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Business Intelligence, Vertical SaaS

Business Model

B2B

Customer Profile

Subscription SaaS

AI Layer

Application

Keywords

life sciences dealmakingdrug asset valuationscientific due diligencebiotech deal intelligencevertical SaaSpharma M&AAI-native platformdrug development dataclinical strategydeal intelligencebiotech investingpharma deal flowbiotech deal flowbiotech softwarepharma software

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Prudentia Sciences Comparables

Compare Prudentia Sciences with similar companies based on industry and business-model similarity.

Prudentia Sciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
One Zyme
88%
SNAP Life Sciences
86%
PhaseFolio
80%

Prudentia Sciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJan 7, 2026
SeedJan 9, 2025

Key People

Founding team and executive leadership

Sadiqa Mahmood

CEO & Founder

Founding Team

John Reynders

Chief Technology Officer

Executive Team

Sean O'Shea

Chief Technology Officer

Executive Team

Prudentia Sciences Investors

Notable investors and investment history

Prudentia Sciences investors
InvestorRounds
Iaso VenturesSeries A, Seed
GVSeries A, Seed
McKesson VenturesSeries A
McKesson VenturesSeries A
SignalFireSeries A
VirtueSeries A, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 30, 2026

    Grew 20% QoQ, from 20 to 24 employees.

  • Jul 18, 2026

    Grew 29% QoQ, from 17 to 22 employees.

Prudentia Sciences Filings

Explore SEC and related filing metadata, where available.

Prudentia Sciences filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Prudentia Sciences's valuation, stock price, and market status.

Is Prudentia Sciences a public or private company?

Prudentia Sciences is a private company.

What is the current stock price of Prudentia Sciences?

Prudentia Sciences is a private company with no public stock price. No recent secondary market data is available.

How much is Prudentia Sciences worth (valuation)?

Valuation information for Prudentia Sciences is not publicly available.

Can I buy Prudentia Sciences stock?

Prudentia Sciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Prudentia Sciences's last funding round?

Prudentia Sciences's most recent funding round was Series A on January 7, 2026.

Who are the main investors in Prudentia Sciences?

Key investors in Prudentia Sciences include GV, McKesson Ventures, McKesson Ventures.

Will Prudentia Sciences IPO soon?

No public IPO plans have been announced for Prudentia Sciences.

How can I track Prudentia Sciences secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Prudentia Sciences's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCambridge, Massachusetts
Employee Range21
Year Founded2023
Last FundingJan 7, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?